EN
EN
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment
Be the global leader of T cell cancer immunotherapy
 
HomeAbout TCRCureCore Team
Core Team
Management Team
  • Qi-Jing Li
    Qi-Jing Li
    Ph.D., Co-founder
    Expert in TCR antigen recognition, T cell function; participated in China's first CD19 CAR-T IND.
  • Pin Wang
    Pin Wang
    Ph.D., Co-founder
    Expert in immuno-engineering, viral manufacturing; Scientific founder of Immune Design (acquired by Merk).
  • Frank Su
    Frank Su
    M.D., MBA, Co-founder
    Veteran entrepreneur, biotech investor;
    Extensive clinical development, BD experience.
  • Wei-Wu He
    Wei-Wu He
    Ph.D., MBA, Co-founder
    25+ years industry experience; 20+ years in VC;
    Founder of >20 biotechs, with strong focus on bioinformatics, data-driven therapy.
  • Si Li
    Si Li
    Ph.D., CTO
    Cancer immunologist with specialization in cell engineering, gene therapy, and virology.
  • Ling Peng
    Ling Peng
    M.D.,Ph.D., Medical Director
    15 years of clinical oncologist;
    Rich experience in tumor immunotherapy.
  • Li-Feng Zhang
    Li-Feng Zhang
    Ph.D., R&D Director, PI Head
    18+ years research experience with deep expertise in cell biology and cell therapy.
  • Dawn Sheng
    Dawn Sheng
    J.D., Head of Legal & Compliance
    Experienced in corporate legal affairs;
    Well-trained attorney in China and the United States (Sidley, Weil, King & Wood Mallesons)

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
Contact Us
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer